CoChat
Sign Up
Cited by 137Hepatitis Viruses Studies and EpidemiologyHepatitis B Virus StudiesViral gastroenteritis research and epidemiology

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Immunoglobulin prophylaxis for hepatitis A.

Winokur, P. L., Stapleton, J. T.·1992·Clinical Infectious Diseases
DOI 10.1093/clinids/14.2.580
Open this paper in CoChat — free account

Abstract

Studies conducted over the past 45 years have shown that immunoglobulin (IG) prevents 80%-90% of cases of hepatitis A when administered before exposure or shortly thereafter. Protection is short lived and requires early diagnosis and timely administration of IG to contacts. Inactivated and attenuated hepatitis A virus (HAV) vaccines have recently been developed and should be available for clinical use within the next few years. Evaluation of antibodies to HAV in IG and in IG recipients provides one method of determining the immunogenicity of HAV vaccines. The role of IG in the prevention of hepatitis A is reviewed with emphasis on the relationship of antibody response following IG administration to the efficacy of HAV vaccines.

Overview

Integrity signals

Registry

Crossref · 10.1093/clinids/14.2.580

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Cited by

Sorted by citations

See all 137

Related

Metadata

Authors
Winokur, P. L., & Stapleton, J. T.
Affiliations
University of Iowa (US)
Corresponding author
Stapleton, J. T.
ORCID
Venue
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Published
1992-02-01
Volume
14
Issue
2
Pages
580-586
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
DOI
10.1093/clinids/14.2.580
OpenAlex
W2017352315
Cited by
136
References
73
Citations by year
2025: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 3
FWCI
5.47
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
Keywords
hepatitis A, immunoglobulin prophylaxis, hepatitis A virus, inactivated vaccine, live attenuated vaccine, vaccine immunogenicity, antibody response, post-exposure prophylaxis
MeSH terms
Hepatitis A, Humans, Immunization, Passive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review